NASDAQ: EGRX - Eagle Pharmaceuticals, Inc.

Lønnsomhet i seks måneder: -69.27%
Utbytte: 0.00%
Sektor: Healthcare

Nyheter
Ingen nyheter funnet ennå for "Eagle Pharmaceuticals, Inc."